Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. - ROEverified

COLL

Price:

$33.54

Market Cap:

$1.09B

Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular drug is prescribed for patients experiencing severe, persistent pain that necessitates daily, continuous, long-term opioid therapy. The company's portfolio also encompasses Nucynta ER and Nucynta IR, which are extended-release and immediate-release versions of tapentadol, respective...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2015-05-07

Stock Exchange

NASDAQ

Ticker

COLL

The ROE as of June 2026 (TTM) for Collegium Pharmaceutical, Inc. (COLL) is 26.74%

According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current ROE is 26.74%. This represents a change of 297.81% compared to the average of 6.72% of the last 4 quarters.

Collegium Pharmaceutical, Inc. (COLL) Historical ROE (quarterly & annually)

How has COLL ROE performed in the past?

The mean historical ROE of Collegium Pharmaceutical, Inc. over the last ten years is -9.79%. The current 26.74% ROE has changed -373.03% with respect to the historical average. Over the past ten years (40 quarters), COLL's ROE was at its highest in in the June 2021 quarter at 28.78%. The ROE was at its lowest in in the September 2016 quarter at -35.58%.

Quarterly (TTM)
Annual

Average

-9.79%

Median

0.77%

Minimum

-71.93%

Maximum

35.24%

Collegium Pharmaceutical, Inc. (COLL) ROE by Quarter and Year

Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 145.07%

Maximum Annual ROE = 35.24%

Minimum Annual Increase = -292.02%

Minimum Annual ROE = -71.93%

Quarterly (TTM)
Annual
YearROEChange
202520.84%-31.07%
202430.23%22.70%
202324.64%-292.02%
2022-12.83%-136.41%
202135.24%145.07%
202014.38%-155.33%
2019-25.99%-39.17%
2018-42.72%-40.60%
2017-71.93%3.04%
2016-69.81%117.89%

Collegium Pharmaceutical, Inc. (COLL) Average ROE

How has COLL ROE performed in the past?

The current ROE of Collegium Pharmaceutical, Inc. (COLL) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

25.24%

5-year avg

19.63%

10-year avg

-9.79%

Collegium Pharmaceutical, Inc. (COLL) ROE vs. Peers

How is COLL’s ROE compared to its peers?

Collegium Pharmaceutical, Inc.’s ROE is less than Amphastar Pharmaceuticals, Inc. (10.23%), greater than Dynavax Technologies Corporation (-8.05%), greater than Cronos Group Inc. (-0.19%), less than GoodRx Holdings, Inc. (3.31%), less than Innoviva, Inc. (47.59%), less than Pacira BioSciences, Inc. (0.73%), less than MiMedx Group, Inc. (12.86%), greater than Pulse Biosciences, Inc. (-86.67%), greater than Atai Beckley Inc. (-366.49%), greater than Nektar Therapeutics (-87.00%),

Build a custom stock screener for Collegium Pharmaceutical, Inc. (COLL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Collegium Pharmaceutical, Inc. (COLL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Collegium Pharmaceutical, Inc.'s ROE?

How is the ROE calculated for Collegium Pharmaceutical, Inc. (COLL)?

What is the highest ROE for Collegium Pharmaceutical, Inc. (COLL)?

What is the 3-year average ROE for Collegium Pharmaceutical, Inc. (COLL)?

What is the 5-year average ROE for Collegium Pharmaceutical, Inc. (COLL)?

How does the current ROE for Collegium Pharmaceutical, Inc. (COLL) compare to its historical average?